Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn Pharmaceutical Technology 10:14 Fri, 08 May
Family-Run Angelini Pharma Buys Catalyst Pharmaceuticals For Over 4 Billion Benzinga 17:00 Thu, 07 May Article paywall
Cprx Stock Alert: Halper Sadeh LLC is Investigating Whether Catalyst Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders Business Wire (Press Release) 12:30 Thu, 07 May
STAT Plus: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B STAT 09:43 Thu, 07 May
A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Firdapse Momentum And Growing Agamree Contribution Simply Wall St 23:00 Sun, 26 Apr
Catalyst Pharmaceuticals (CPRX) Is Up 5.3% After Stronger Revenue And Expanded M&A Pipeline - What's Changed Simply Wall St 10:49 Sat, 18 Apr
Is Catalyst Pharmaceuticals (CPRX) Still Attractive After Strong Multi‑Year Share Price Gains? Simply Wall St 22:42 Sat, 11 Apr
